Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Role of Endothelin-1 in Mediating Flow-mediated Dilatation of Conduit Arteries
NCT02086253Completed
- Sponsor
- Rouen University Hospital
- Start
- Feb 2014
- Primary completion
- May 2014
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Trial of BQ-788 and BQ-123 (3 arms), sponsored by Rouen University Hospital. Primary endpoint: Effect of ETB receptor blockade on flow-mediated dilatation at 1 hour. Started Feb 2014; status: completed.
02
Drugs
BQ-788BQ-123
Beyond the preview
Go deeper on NCT02086253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02086253.